![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
for ethnowoman
Dec. 16th, 2013 11:42 amThe selling of Attention Deficit Disorder, in the NY Times.
It's really hard to know what's true, when so many of the sources of information are comprimised by commercial interests.
I find it hard to believe that an MD researcher who receives millions in speaking fees from a pharam company isn't influenced by their funding. How on earth would your research ever say, 'actually, we've discovered ADD isn't that common, we should reclassify this drug' after you've taken their money?
The marketing to parents is just insidious.
It's really hard to know what's true, when so many of the sources of information are comprimised by commercial interests.
I find it hard to believe that an MD researcher who receives millions in speaking fees from a pharam company isn't influenced by their funding. How on earth would your research ever say, 'actually, we've discovered ADD isn't that common, we should reclassify this drug' after you've taken their money?
The marketing to parents is just insidious.
